The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis | |
Cheng, Wei2; Wang, Hongzhi3; Yuan, Juanjuan1; Cheng, Ziwei2; Xing, Dongwei2; Zhang, Minguang2 | |
刊名 | BIOMED RESEARCH INTERNATIONAL
![]() |
2018 | |
页码 | 10 |
ISSN号 | 2314-6133 |
DOI | 10.1155/2018/3429261 |
通讯作者 | Xing, Dongwei(xdw021@163.com) ; Zhang, Minguang(mgzhang09@163.com) |
英文摘要 | Background. Recent several studies have showed that the nanog overexpression leads to poor prognosis in some kinds of cancer including hepatocellular carcinoma and gastrointestinal luminal cancer. However, the correlations between prognosis and clinic-pathological features and nanog overexpression in lung cancer are still not well-known. Thus, we performed a meta-analysis to evaluate the role of nanog in lung cancer. Methods. An electronic retrieval for related studies was conducted in PubMed, Cochrane Library, Web of Science, EMBASE databases, Chinese CNKI, and the Chinese Wan Fang database up to May 2018. The relationships between nanog overexpression and overall survival (OS) and disease-free survival (DFS) as well as clinic-pathological features in lung cancer were investigated. Pooled hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated by STATA12. Results. 11 studies containing 1422 patients were identified in our meta-analysis. The overexpression of nanog showed decreased OS (HR = 1.83, 95% CI = 1.49-2.25, P 0.001) and DFS (HR = 1.86, 95% CI = 1.2-2.9, P = 0.006). Moreover, overexpression of nanog was significantly related to differentiation (OR = 4.17, 95% CI = 2.17-6.43, P 0.001), lymph node metastasis (OR = 1.76, 95% CI = 1.06-2.91, P = 0.028) and tumor size (OR = 1.93, 95% CI = 1.17-3.20, P = 0.010), and no correlation with T stage, TNM, stage, and gender. Conclusions. Our results suggested that nanog overexpression, a hazard factor of differentiation, lymph node metastasis, and tumor size, may predicate decreased OS and DFS for lung cancer. |
资助项目 | National Natural Science Foundation of China[81673743] |
WOS关键词 | STEM-CELLS ; STATISTICS ; EXPRESSION ; MARKER |
WOS研究方向 | Biotechnology & Applied Microbiology ; Research & Experimental Medicine |
语种 | 英语 |
出版者 | HINDAWI LTD |
WOS记录号 | WOS:000453720300001 |
资助机构 | National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China ; National Natural Science Foundation of China |
内容类型 | 期刊论文 |
源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/41140] ![]() |
专题 | 中国科学院合肥物质科学研究院 |
通讯作者 | Xing, Dongwei; Zhang, Minguang |
作者单位 | 1.Anhui Med Univ, Peoples Hosp Hefei 2, Hefei Hosp, Hefei 230011, Anhui, Peoples R China 2.Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai 200071, Peoples R China 3.Chinese Acad Sci, Canc Hosp, Hefei 230011, Anhui, Peoples R China |
推荐引用方式 GB/T 7714 | Cheng, Wei,Wang, Hongzhi,Yuan, Juanjuan,et al. The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis[J]. BIOMED RESEARCH INTERNATIONAL,2018:10. |
APA | Cheng, Wei,Wang, Hongzhi,Yuan, Juanjuan,Cheng, Ziwei,Xing, Dongwei,&Zhang, Minguang.(2018).The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis.BIOMED RESEARCH INTERNATIONAL,10. |
MLA | Cheng, Wei,et al."The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis".BIOMED RESEARCH INTERNATIONAL (2018):10. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论